Zobrazeno 1 - 10
of 34
pro vyhledávání: ''
Autor:
Marcella G Del Carmen, Annekathryn Goodman, Michelle Davis, Neil E Horowitz, Whitfield B. Growdon, Susanna I. Lee, Colleen M. Feltmate, Jessica D. St. Laurent
Publikováno v:
American Journal of Clinical Oncology. 43:714-719
OBJECTIVE 18F-fluorodeoxyglucose positron emission tomography-computed tomography (PET-CT) increases the sensitivity for preoperative detection of lymph nodes and distant metastases in endometrial cancer. The objective of this investigation was to de
Publikováno v:
Clinical Nuclear Medicine. 45:e232-e235
Radiolabeled somatostatin analogs for somatostatin receptor (SSTR)-targeted imaging and peptide receptor radionuclide therapy (PRRT) have demonstrated remarkable success in the management of SSTR-expressing neuroendocrine neoplasms. Primary neuroendo
Autor:
Niels J. Rupp, Martina Baněčková, Stephan Ihrler, Alena Skálová, Tomas Vanecek, Marco Schiavo-Lena, Patrizia Morbini, Michal Michal, Abbas Agaimy, Thalita Santana, Justin A. Bishop, Emmanuelle Uro-Coste, Lester D.R. Thompson, Nikola Ptáková, Stefano De Sanctis, Ilmo Leivo
Publikováno v:
American Journal of Surgical Pathology. 43:1303-1313
Intraductal carcinoma (IC) is the new WHO designation for tumors previously encompassed by "low-grade cribriform cystadenocarcinoma" and "low-grade salivary duct carcinoma." The relationship of IC to salivary duct carcinoma (SDC) is controversial, ev
Autor:
Yasunori Nishida, Atsushi Ochiai, Aoi Sukeda, Motohiro Kojima, Naoto Gotohda, Tetsuo Akimoto, Yuka Nakamura
Publikováno v:
Pancreas. 48:1102-1110
Objectives Because lactate is believed to support tumor growth, monocarboxylate transporters (MCTs), which transport lactate, have been investigated in multiple tumors. However, the significance of MCTs in pancreatic cancer is unclear. Methods A retr
Autor:
Upendra Parvathaneni, Ashwin Shinde, Badri Modi, Bernard L. Jones, Scott M. Glaser, Richard Li, Robert Kang, Arya Amini, Vivek Verma, Morganna Freeman, Laleh G. Melstrom
Publikováno v:
American Journal of Clinical Oncology. 42:636-642
OBJECTIVES Delays from surgery to adjuvant radiation therapy (aRT) are associated with poorer prognosis in multiple neoplasms. Presently, no data exist for Merkel cell carcinoma (MCC). The authors sought to assess the time interval from surgery to aR
Autor:
Kohei Ogawa, Masatoshi Jinnin, Toshihiro Takai, Yuki Yamamoto, Yoshifumi Iwahashi, Yuichi Takahashi, Shin-ichi Murata, Fumiyoshi Kojima, Kenji Warigaya, Takanori Yoshikawa, Masakazu Fujimoto, Noriki Fujimoto, Ibu Matsuzaki
Publikováno v:
American Journal of Surgical Pathology. 43:975-983
Although most cases of early cutaneous squamous cell carcinoma (CSCC) are indolent, a small subset metastasize and can be fatal. However, high-risk features of CSCC are controversial, and it is difficult to predict the biological behavior. In this st
Publikováno v:
American Journal of Clinical Oncology. 42:292-297
OBJECTIVES Metastatic non-small cell lung cancer (NSCLC) has a poor prognosis. Most patients present with stage IV, and many patients treated curatively with stage I to III develop recurrent metastatic disease. It is unknown whether the natural histo
Autor:
Ying Sun, Guang Shi, Qiang Feng, Yingqi Liu, Xueqiang Zhang, Jianjun Jiao, Chao Ma, Qingling Gao
Publikováno v:
Medicine
A kinase interacting protein 1 (AKIP1) is upregulated in cancer cells/tissues and associated with deteriorative tumor features, while it has not been investigated in tongue squamous cell carcinoma (TSCC). The goal of this study was to measure AKIP1 e
Publikováno v:
Medicine
Angiogenic factor with G-patch and FHA domain 1 (AGGF1) is a newly initiator of angiogenesis. Forkhead box C2 (FOXC2) that is a member of the winged spiral transcription factor family plays an important role in epithelial-mesenchymal transition (EMT)
Autor:
Annekathryn Goodman, Whitfield B. Growdon, Joel Clemmer, Roberto J. Vargas, Marcela G. del Carmen, David M. Boruta, John O. Schorge, Jose Alejandro Rauh-Hain, Rachel M. Clark, Leslie S. Bradford
Publikováno v:
American Journal of Clinical Oncology. 39:43-48
Mucinous endometrial cancer (MEC) is a rare histologic subtype of endometrial cancers. The purpose of this study is to compare the outcomes of patients with MEC with patients with endometrioid endometrial cancers (EEC), and to determine whether there